The company and the drug: EmeraMed Ltd is a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator and antioxidant Irminix® (Code: NBMI, INN: Emeramide).
- Mercury poisoning: Orphan Drug Designation has been granted for the Prevention and Treatment of Mercury toxicity in the EU and USA. Phase 1 and Phase 2a clinical studies have been performed.
- COPD: A Phase 2a clinical trial to be completed summer 2018.
- Other conditions: Preclinical studies ongoing for other indications.
Early access/Individual Patient treatments: There are a growing number of approvals and shippings to Switzerland, Germany, Austria, New Zealand, UK, Lebanon and the USA for Individual Patient use. For more information – please click above or download word document here.
Subscribe To Our Mailing List: (* indicates required)
Warning – Chinese NBMI/Emeramide sold illegally in EU & USA
Irminix®/NBMI/Emeramide is a patented drug. A drug needs an approval from FDA or EMA in order to be sold legally. A drug needs to be manufactured according to rigorous quality standards set by the FDA or EMA. The Chinese powder that is usurping our drug name has none of the safeguards required by the US and EU and is illegal and poses a health threat.
No one knows what chemicals are actually in the illegal Chinese powder or what additives are contaminating it. The tube to the right in the photo shows what happens when trying to dissolve the Chinese product. The solution in the Chinese product should have been clear like our pharmaceutical grade product shown in the left tube.
On 20 August 2018, Reuters reported that a Chinese made approved drug was pulled from the European Market “after detection of a toxic impurity that may cause cancer.” (link here). And that was an approved drug, supposedly produced under pharmaceutical grade conditions. The Chinese made counterfeit product is not even produced under pharmaceutical grade conditions.
Do not risk your health with Chinese counterfeits, YOU ARE RISKING THE HEALTH of yourself or your loved one. Instead consider legal options such as Individual Patient IND application with the FDA with the authentic medicine – information is found by clicking Early Access
above or by downloading the application document found here.
The companies selling NBMI/Emeramide are being reported to the FDA and EMA.